作者:Joseph H. Chan、George A. Freeman、Jeffrey H. Tidwell、Karen R. Romines、Lee T. Schaller、Jill R. Cowan、Steve S. Gonzales、Gina S. Lowell、C. W. Andrews、David J. Reynolds、Marty St Clair、Richard J. Hazen、Rob G. Ferris、Katrina L. Creech、Grace B. Roberts、Steven A. Short、Kurt Weaver、George W. Koszalka、Lawrence R. Boone
DOI:10.1021/jm030255y
日期:2004.2.1
GW4511, GW4751, and GW3011 showed IC50 values less than or equal to2 nM against wild type HIV-1 and <10 nM against 16 mutants. They were particularly potent against NNRTI-resistant viruses containing Y181C-, K103N-, and K103N-based double mutations, which account for a significant proportion of the clinical failure of the three currently marketed NNRTIs. The antiviral data together with the favorable pharmacokinetic data of GW4511 suggested that these benzophenones possess attributes of a new NNRTI drug candidate.